About
Investment Analyst sourcing and evaluating opportunities across Europe. Joined in 2026 after roles at Sound Bioventures, Health Innovation Capital, Distributed Bio, and CERo Therapeutics. Holds a PhD in Molecular Medicine from EMBL and Heidelberg University Hospital.
Colleagues at Mission Biocapital
Cassidy Blundell
Partner at Mission Biocapital
Chaya Patel
Principal at Mission Biocapital
Chris Carlin
Chief Operations Officer and Chief Compliance Officer at Mission Biocapital
Clay Rowland
Investment Associate at Mission Biocapital
Douglas Crawford
Managing General Partner at Mission Biocapital
Helen Siaw
Analyst at Mission Biocapital
Jennifer Griffin
Partner at Mission Biocapital
Johannes Fruehauf
General Partner at Mission Biocapital